Nefazodone in the Treatment of Social Phobia

Completed · Phase 4

Conditions studied: Social Anxiety Disorder (SAD)

In brief

The purpose of this study is to determine the effectiveness of nefazadone in patients with social anxiety disorder (SAD).

Key facts

Study ID

NCT00231348

Run by

Emory University

People needed

24

Expected to finish

2000-04-01

Last updated by the study team

2013-11-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• DSM-IV diagnosis of generalized social anxiety disorder, males and females between the ages of 18-65

You may not qualify if…

• A history of bipolar disorder, psychotic illness, or any other anxiety disorders, organic brain disease or active drug or alcohol abuse within one year as assessed by the SCID-P and interview, or a concurrent medical condition that would not be compatible with the study in the opinion of the principal investigator. Patients required to be free of psychotropic or beta-blocker medication for 2 weeks prior to study. Pts taking fluoxetine required to be drug-free for 6 weeks.

Where it is running

• Emory University Depatment of Psychiatry and Behavioral Sciences — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.